The FDA PDUFA VII Goals Letter (FY 2023-2027): A Review of Our Top 10 Commitments
FDA Law Blog
SEPTEMBER 20, 2021
STAR aims to facilitate earlier access to novel uses of existing therapies for patients with a serious condition with unmet medical needs. 31, 2022; CDRP start, FY 2023; Public workshop, by July 31, 2025; Strategy document published, by April 30, 2026. Notable Dates and Timelines – New MAPP published, by Dec.
Let's personalize your content